This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
27 - 29 May, 2026
Congress CenterBasel Switzerland

Hung-En Hsia, PhD
Bioanalytical Scientist at Roche Innovation Center Munich
Speaker

Profile

Hung-En Hsia completed her doctorate in Neuroscience in Göttingen, Germany. Before joining Roche, she did her postdoc at the German Center for Neurodegenerative Diseases (DZNE) in Munich, where she worked on membrane proteases related to Alzheimer’s disease and pharmacodynamic biomarkers. At Roche, she has been working on engineered antibody-oligonucleotide conjugates or complexes with improved pharmacokinetic profiles. She continues her journey at Roche as a Bioanalytical and Biomarker Scientist

Agenda Sessions

  • Engineered Antibodies to Improve Brain Delivery of Oligonucleotide

    10:00